INTERNATIONAL PATENT: IGNIS THERAPEUTICS (SUZHOU) LIMITED FILES APPLICATION FOR "COMBINATION OF A 5-HT2A RECEPTOR AGONIST AND AN M4 ACTIVATOR AND USE THEREOF"

GENEVA, March 16 -- IGNIS THERAPEUTICS (SUZHOU) LIMITED (46F, BM InterContinental Business Center, 100 Yu Tong RoadJingan District, Shanghai 200070) filed a patent application (PCT/CN2025/119579) for "COMBINATION OF A 5-HT2A RECEPTOR AGONIST AND AN M4 ACTIVATOR AND USE THEREOF" on Sep 08, 2025. With publication no. WO/2026/052097, the details related to the patent application was published on Mar 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SUN, Yishan (46F, BM InterContinental Business Center, 100 Yu Tong RoadJingan District, Shanghai 200070), HAO, Junliang (46F, BM InterContinental ...